2025 | 2024 | ||
Note | £m | £m | |
Revenue | 2 | ||
Cost of sales | ( | ( | |
Gross profit | |||
Selling and distribution expense | ( | ( | |
Administrative expense | ( | ( | |
Share of results of joint venture | 14 | ||
Operating profit/(loss) | 2 | ( | |
Finance income | |||
Finance expense | ( | ( | |
Net finance expense | 6 | ( | ( |
Net monetary gain/(loss) arising from hyperinflationary economies 1 | ( | ||
Profit/(loss) before taxation | ( | ||
Taxation | 7 | ( | |
Loss for the year 2 | 4 | ( | ( |
Attributable to: | |||
Owners of the Parent | ( | ( | |
Non-controlling interests | ( | ||
( | ( | ||
pence | pence | ||
Loss per share 2 | |||
Basic (p) | 9 | ( | ( |
Diluted (p) 3 | 9 | ( | ( |
2025 | 2024 | ||
Note | £m | £m | |
Loss for the year | ( | ( | |
Other comprehensive (expense)/income | |||
Items that will not be reclassified subsequently to income statement | |||
Re-measurement loss on net retirement benefit surplus | 23 | ( | ( |
Taxation on other comprehensive (expense)/income | 21 | ||
Total items that will not be reclassified to income statement | ( | ( | |
Items that may be reclassified subsequently to income statement | |||
Exchange differences on translation of foreign operations 1 | ( | ||
Share of other comprehensive expense of joint venture accounted for using the equity method | ( | ( | |
Cash flow hedges – fair value movements | ( | ||
Total items that may be subsequently reclassified to income statement | ( | ( | |
Other comprehensive expense for the year | ( | ( | |
Total comprehensive expense for the year | ( | ( | |
Attributable to: | |||
Owners of the Parent | ( | ( | |
Non-controlling interests | ( | ||
( | ( |
2025 | 2024 | ||
Note | £m | £m | |
Assets | |||
Non-current assets | |||
Goodwill and other intangible assets | 10 | ||
Property, plant and equipment | 11 | ||
Investment properties | 12 | ||
Right-of-use assets | 13 | ||
Net investment in joint venture | 14 | ||
Trade and other receivables | 17 | ||
Deferred tax assets | 21 | ||
Tax receivable | |||
Retirement benefit surplus | 23 | ||
Current assets | |||
Inventories | 16 | ||
Trade and other receivables | 17 | ||
Derivative financial assets | 19 | ||
Current taxation receivable | |||
Cash and cash equivalents | 18 | ||
Assets held for sale | 15 | ||
Total assets | |||
Equity | |||
Share capital | 24 | ||
Treasury shares | 24 | ( | ( |
Capital redemption reserve | |||
Hedging reserve | 19 | ( | ( |
Currency translation reserve | ( | ( | |
Retained earnings | |||
Other reserves | |||
Attributable to owners of the Parent | |||
Non-controlling interests | ( | ( | |
Total equity |
2025 | 2024 | ||
Note | £m | £m | |
Liabilities | |||
Non-current liabilities | |||
Borrowings | 18, 19 | ||
Trade and other payables | 20 | ||
Lease liabilities | 19 | ||
Deferred taxation liabilities | 21 | ||
Retirement and other long-term employee benefit obligations | 23 | ||
Current liabilities | |||
Borrowings | 18, 19 | ||
Trade and other payables | 20 | ||
Lease liabilities | 19 | ||
Derivative financial liabilities | 19 | ||
Current taxation payable | |||
Provisions | 22 | ||
Total liabilities | |||
Total equity and liabilities |
Attributable to owners of the Parent | ||||||||||
Capital | Currency | Non- | ||||||||
Share | Treasury | redemption | Hedging | translation | Retained | Other | controlling | |||
capital | shares | reserve | reserve 1 | reserve 2 | earnings | reserves 3 | interests 4 | Total | ||
Note | £m | £m | £m | £m | £m | £m | £m | £m | £m | |
At 1 June 2023 | ( | ( | ||||||||
Loss for the year | ( | ( | ( | |||||||
Other comprehensive expense | ( | ( | ( | ( | ( | |||||
Total comprehensive expense for the year | ( | ( | ( | ( | ( | |||||
Transactions with owners: | ||||||||||
Ordinary dividends | 8 | ( | ( | |||||||
Share-based payments | 25 | |||||||||
Shares issued from ESOT | ( | |||||||||
Total transactions with owners | ( | ( | ||||||||
recognised directly in equity | ||||||||||
At 31 May 2024 | ( | ( | ( | ( | ||||||
At 1 June 2024 | ( | ( | ( | ( | ||||||
(Loss)/Profit for the year | ( | ( | ||||||||
Other comprehensive income/ | ( | ( | ||||||||
(expense) | ||||||||||
Total comprehensive income/ | ( | ( | ||||||||
(expense) for the year | ||||||||||
Transactions with owners: | ||||||||||
Ordinary dividends | 8 | ( | ( | |||||||
Share-based payments | 25 | ( | ||||||||
Shares issued from ESOT | ( | |||||||||
Total transactions with owners | ( | ( | ( | |||||||
recognised directly in equity | ||||||||||
At 31 May 2025 | ( | ( | ( | ( |
2025 | 2024 | ||
Note | £m | £m | |
Cash flows from operating activities | |||
Cash generated from operations | 26 | ||
Interest paid | ( | ( | |
Taxation paid | ( | ( | |
Net cash generated from operating activities | |||
Cash flows from investing activities | |||
Interest received | |||
Purchase of fixed assets | 10, 11, 12 | ( | ( |
Proceeds from disposal of fixed assets | |||
Cash flow from disposal of current asset investment | |||
Rental income | |||
Loans advanced to joint venture | ( | ||
Loan repayments from joint venture | |||
Net cash (used in)/generated from investing activities | |||
Cash flows from financing activities | |||
Dividends paid to Company shareholders | 8 | ( | ( |
Acquisition of non-controlling interests | ( | ||
Repayment of lease liabilities | ( | ( | |
Repayment of borrowings | ( | ( | |
Proceeds from borrowings | |||
Financing fees paid on committed credit facility | ( | ( | |
Net cash used in financing activities | ( | ( | |
Net decrease in cash and cash equivalents | ( | ( | |
Effect of foreign exchange rates | ( | ( | |
Cash and cash equivalents at the beginning of the year | |||
Cash and cash equivalents at the end of the year | 18 |
Europe & the | ||||||
Americas | Asia Pacific | Africa | Central | Eliminations | Total | |
2025 | £m | £m | £m | £m | £m | £m |
Gross segment revenue | 202.5 | 175.3 | 140.9 | 40.2 | (45.1) | 513.8 |
Inter-segment revenue | (3.1) | (1.8) | — | (40.2) | 45.1 | — |
Revenue | 199.4 | 173.5 | 140.9 | — | — | 513.8 |
Segmental operating profit/(loss) before adjusting items and share of results of joint venture | 36.8 | 25.2 | 16.3 | (30.5) | — | 47.8 |
Share of results of joint venture | — | — | 7.1 | — | — | 7.1 |
Segmental operating profit/(loss) before adjusting items | 36.8 | 25.2 | 23.4 | (30.5) | — | 54.9 |
Adjusting items | 14.1 | (0.1) | (4.5) | (43.8) | — | (34.3) |
Segmental operating profit/(loss) | 50.9 | 25.1 | 18.9 | (74.3) | — | 20.6 |
Finance income | 3.9 | |||||
Finance expense | (18.0) | |||||
Net monetary gain arising from hyperinflationary economies | — | |||||
Profit before taxation | 6.5 |
Europe & the | ||||||
Americas | Asia Pacific | Africa | Central | Eliminations | Total | |
2024 | £m | £m | £m | £m | £m | £m |
Gross segment revenue | 204.1 | 179.2 | 151.7 | 34.2 | (41.3) | 527.9 |
Inter-segment revenue | (3.4) | (4.0) | — | (33.9) | 41.3 | — |
Revenue | 200.7 | 175.2 | 151.7 | 0.3 | — | 527.9 |
Segmental operating profit/(loss) before adjusting items and share of results of joint venture | 32.6 | 28.0 | 19.6 | (32.6) | — | 47.6 |
Share of results of joint venture | — | — | 10.7 | — | — | 10.7 |
Segmental operating profit/(loss) before adjusting items | 32.6 | 28.0 | 30.3 | (32.6) | — | 58.3 |
Adjusting items | (31.9) | (1.0) | (81.0) | (28.1) | — | (142.0) |
Segmental operating profit/(loss) | 0.7 | 27.0 | (50.7) | (60.7) | — | (83.7) |
Finance income | 12.2 | |||||
Finance expense | (24.2) | |||||
Net monetary loss arising from hyperinflationary economies | (0.2) | |||||
Loss before taxation | (95.9) |
2025 | 2024 | |
£m | £m | |
Hygiene | 285.5 | 289.1 |
Baby | 106.6 | 106.9 |
Beauty | 65.4 | 68.3 |
Electricals | 47.0 | 56.6 |
Other | 9.3 | 7.0 |
513.8 | 527.9 |
2025 | 2024 | |
£m | £m | |
Simplification and transformation 1 | 8.7 | 10.1 |
Acquisition and disposal-related items 2 | 1.7 | (1.4) |
Impairment charge (net of impairment reversal) 1 | 18.8 | 24.4 |
Foreign exchange losses on Nigerian Naira devaluation 3 | — | 104.1 |
Foreign exchange losses on Nigerian Naira devaluation on joint venture 4 | — | 3.4 |
Foreign exchange losses arising on loans previously classified as permanent as equity 1 | 3.9 | — |
Foreign exchange losses arising on loans previously classified as permanent as equity to joint venture undertaking 4 | 1.5 | — |
Adjusting items before taxation | 34.6 | 140.6 |
Taxation | 2.7 | (30.6) |
Adjusting items after taxation | 37.3 | 110.0 |
2025 | 2024 | |
£m | £m | |
Net foreign exchange losses | 7.8 | 124.6 |
Research and development costs | 1.1 | 0.5 |
Depreciation of property, plant and equipment | 5.1 | 7.0 |
Depreciation of investment properties | 0.1 | 0.1 |
Depreciation of right-of-use assets | 2.8 | 3.2 |
Profit on disposal of property, plant and equipment | — | (1.8) |
Profit on disposal of other assets | (1.1) | — |
Amortisation of intangible assets | 4.1 | 7.1 |
Impairment of intangible assets, net of impairment reversal (note 10) | 18.8 | 24.4 |
2025 | 2024 | |
£m | £m | |
Fees payable to the Company’s Auditor for the audit of the Company’s annual financial statements and consolidation | 2.0 | 2.3 |
Fees payable to the Company’s Auditor and their associates for other services to the Group: | ||
– audit of the Company’s subsidiaries | 2.0 | 1.7 |
Fees payable to the Company’s previous Auditor and their associates for other services to the Group: | ||
– audit of the Company’s subsidiaries | — | 0.4 |
Total audit fees | 4.0 | 4.4 |
Fees payable to the Company’s Auditor and its associates for other services: | ||
– Other assurance services 1 | 0.2 | 0.3 |
Total fees for non-audit services | 0.2 | 0.3 |
Total auditor's remuneration | 4.2 | 4.7 |
2025 | 2024 | |
number | number | |
Production | 1,379 | 1,621 |
Selling and distribution | 647 | 599 |
Administration | 385 | 347 |
2,411 | 2,567 |
2025 | 2024 | |
£m | £m | |
Wages and salaries | 64.6 | 69.2 |
Social security costs | 5.7 | 5.1 |
Pension costs | 3.3 | 3.5 |
Share-based payments | 2.6 | 1.9 |
76.2 | 79.7 |
2025 | 2024 | |
£m | £m | |
Defined benefit schemes | 1.3 | 1.3 |
Defined contribution schemes | 1.8 | 1.9 |
Nigerian gratuity scheme | 0.2 | 0.3 |
3.3 | 3.5 |
2025 | 2024 | |
£m | £m | |
Interest receivable on cash and cash equivalents held | (2.4) | (8.9) |
Finance income on defined benefit pension schemes | (1.5) | (1.9) |
Change in fair value of deferred consideration | — | (1.4) |
Finance income | (3.9) | (12.2) |
Interest payable on borrowings | 15.5 | 22.2 |
Finance expense on defined benefit pension schemes | 0.6 | 0.6 |
Interest expense on lease liabilities | 0.6 | 0.5 |
Change in fair value of deferred consideration | 0.3 | — |
Amortisation of financing fees | 1.0 | 0.9 |
Finance expense | 18.0 | 24.2 |
Net finance expense | 14.1 | 12.0 |
2025 | 2024 | |
£m | £m | |
Current taxation | ||
UK corporation tax | ||
– current year | 2.7 | 5.2 |
– adjustments in respect of prior years | (1.6) | 3.5 |
1.1 | 8.7 | |
Overseas corporation tax | ||
– current year | 11.9 | 11.6 |
– adjustments in respect of prior years | (0.2) | (0.8) |
11.7 | 10.8 | |
Total current taxation charge | 12.8 | 19.5 |
Deferred taxation | ||
Origination and reversal of temporary timing differences | 1.5 | (38.0) |
Adjustments in respect of prior years | (2.6) | (6.4) |
Effect of rate change adjustments | — | 0.8 |
Total deferred taxation credit | (1.1) | (43.6) |
Total taxation charge/(credit) | 11.7 | (24.1) |
Analysed as: | ||
Taxation on profit before adjusting items | 9.0 | 6.5 |
Taxation on adjusting items | 2.7 | (30.6) |
11.7 | (24.1) |
2025 | 2024 | |
£m | £m | |
Profit/(loss) before taxation | 6.5 | (95.9) |
Taxation at the UK corporation tax rate of 25% (2024: 25%) | 1.6 | (24.0) |
Adjusted for: | ||
Effect of non-deductible expenses | 13.6 | 6.4 |
Effect of non-taxable income | (2.9) | (3.7) |
Effect of rate changes on deferred taxation (all territories) | — | 0.8 |
Taxation effect of share of results of joint venture | (1.8) | (2.4) |
Other taxes suffered outside of the UK | 3.0 | 2.1 |
Net adjustment to amount carried in respect of uncertain tax positions | 1.0 | 2.4 |
Movements in deferred taxation assets not recognised | 0.1 | 1.7 |
Adjustments in respect of prior years | (4.4) | (3.7) |
Differences in overseas rates | 1.5 | (3.7) |
Taxation charge/(credit) for the year | 11.7 | (24.1) |
2025 | 2024 | |
£m | £m | |
Amounts recognised as distributions to ordinary shareholders in the year comprise: | ||
Final dividend for the year ended 31 May 2024 of 2.10p (2023: 3.73p) per ordinary share | 8.8 | 15.6 |
Interim dividend for the year ended 31 May 2025 of 1.50p (2024: 1.50p) per ordinary share | 6.3 | 6.3 |
15.1 | 21.9 |
2025 | 2024 | |
number | number | |
000 | 000 | |
Average number of ordinary shares in issue during the year | 428,725 | 428,725 |
Less: weighted average number of treasury shares | (9,268) | (9,693) |
Basic weighted average shares in issue during the year | 419,457 | 419,032 |
Dilutive effect of share incentive schemes | 1,294 | 1,064 |
Diluted weighted average shares in issue during the year | 420,751 | 420,096 |
Goodwill | Software | Brands | Total | |
£m | £m | £m | £m | |
Cost | ||||
At 1 June 2023 | 66.6 | 66.6 | 267.2 | 400.4 |
Additions | — | 0.4 | — | 0.4 |
Exchange differences | — | (1.5) | — | (1.5) |
At 31 May 2024 | 66.6 | 65.5 | 267.2 | 399.3 |
Additions | — | 0.4 | — | 0.4 |
Exchange differences | — | (0.1) | (2.8) | (2.9) |
At 31 May 2025 | 66.6 | 65.8 | 264.4 | 396.8 |
Accumulated amortisation and impairment | ||||
At 1 June 2023 | 10.2 | 41.1 | 36.4 | 87.7 |
Amortisation charge | — | 7.1 | — | 7.1 |
Impairment charge | — | — | 24.4 | 24.4 |
Exchange differences | 1.7 | (1.0) | 0.1 | 0.8 |
At 31 May 2024 | 11.9 | 47.2 | 60.9 | 120.0 |
Amortisation charge | — | 4.1 | — | 4.1 |
Impairment charge | 35.3 | — | — | 35.3 |
Impairment reversal | — | — | (16.5) | (16.5) |
At 31 May 2025 | 47.2 | 51.3 | 44.4 | 142.9 |
Net book value | ||||
At 31 May 2025 | 19.4 | 14.5 | 220.0 | 253.9 |
At 31 May 2024 | 54.7 | 18.3 | 206.3 | 279.3 |
Goodwill | Brands | Goodwill | Brands | |
2025 | 2025 | 2024 | 2024 | |
£m | £m | £m | £m | |
Charles Worthington | 9.6 | 9.6 | ||
Fudge | 24.6 | 24.6 | ||
Sanctuary Spa | 51.0 | 34.5 | ||
St.Tropez | 58.4 | 58.4 | ||
Beauty | 5.1 | 143.6 | 40.4 | 127.1 |
Original Source | — | 9.8 | — | 9.8 |
Rafferty's Garden | — | 31.1 | — | 33.9 |
Childs Farm | 13.5 | 35.5 | 13.5 | 35.5 |
Other | 0.8 | — | 0.8 | — |
19.4 | 220.0 | 54.7 | 206.3 |
Long-term | Long-term | Pre-tax | Pre-tax | |||
CAGR 1 | CAGR 1 | growth rate | growth rate | discount rate | discount rate | |
2025 | 2024 | 2025 | 2024 | 2025 | 2024 | |
Charles Worthington | 2.5% | 6.1% | 2.0% | 2.0% | 13.0% | 11.5% |
Fudge | 0.7% | 2.3% | 2.0% | 2.0% | 13.5% | 11.7% |
Sanctuary Spa | 3.1% | 2.8% | 2.0% | 2.0% | 13.0% | 11.5% |
St.Tropez | 1.3% | 3.3% | 2.0% | 2.0% | 13.5% | 12.0% |
Beauty group of CGUs (goodwill assessment) | 2.0% | 3.2% | 2.0% | 2.0% | 13.3% | 11.6% |
Original Source | 10.2% | 9.9% | 2.0% | 2.0% | 13.1% | 11.6% |
Rafferty's Garden | 2.5% | 4.5% | 2.0% | 2.5% | 13.1% | 11.8% |
Childs Farm (brand and goodwill assessment) | 11.2% | 19.6% | 2.0% | 2.0% | 13.0% | 11.7% |
Fixtures, | Assets in the | ||||
Land and | Plant and | fittings and | course of | ||
buildings | machinery | vehicles | construction | Total | |
£m | £m | £m | £m | £m | |
Cost | |||||
At 1 June 2023 | 75.5 | 119.7 | 51.0 | 3.3 | 249.5 |
Additions | — | — | — | 5.7 | 5.7 |
Disposals | (4.6) | (9.6) | (0.6) | — | (14.8) |
Transfers | 0.3 | 4.1 | 1.4 | (5.8) | — |
Hyperinflationary adjustment 1 | 1.2 | — | — | — | 1.2 |
Exchange differences | (22.7) | (34.0) | (4.9) | (0.5) | (62.1) |
At 31 May 2024 | 49.7 | 80.2 | 46.9 | 2.7 | 179.5 |
Additions | — | 0.1 | 0.2 | 6.0 | 6.3 |
Disposals | — | (1.6) | (7.8) | — | (9.4) |
Transfers | 0.3 | 2.7 | 0.8 | (3.8) | — |
Hyperinflationary adjustment 1 | 0.7 | — | — | — | 0.7 |
Exchange differences | (0.8) | (2.9) | (0.5) | (0.1) | (4.3) |
At 31 May 2025 | 49.9 | 78.5 | 39.6 | 4.8 | 172.8 |
Accumulated depreciation and impairment | |||||
At 1 June 2023 | 34.4 | 99.8 | 47.4 | — | 181.6 |
Depreciation charge | 1.0 | 4.7 | 1.3 | — | 7.0 |
Disposals | (2.6) | (9.5) | (0.7) | — | (12.8) |
Exchange differences | (7.4) | (27.2) | (4.5) | — | (39.1) |
At 31 May 2024 | 25.4 | 67.8 | 43.5 | — | 136.7 |
Depreciation charge | 0.7 | 3.2 | 1.2 | — | 5.1 |
Disposals | — | (1.6) | (7.8) | — | (9.4) |
Exchange differences | (0.2) | (2.3) | (0.5) | — | (3.0) |
At 31 May 2025 | 25.9 | 67.1 | 36.4 | — | 129.4 |
Net book value | |||||
At 31 May 2025 | 24.0 | 11.4 | 3.2 | 4.8 | 43.4 |
At 31 May 2024 | 24.3 | 12.4 | 3.4 | 2.7 | 42.8 |
2025 | 2024 | |
£m | £m | |
Cost | ||
At 1 June | 7.2 | 7.2 |
Additions | 0.2 | 0.3 |
Transfers 1 | — | (0.9) |
Hyperinflation impact 2 | 2.7 | 3.6 |
Exchange differences | 0.5 | (3.0) |
At 31 May | 10.6 | 7.2 |
Accumulated depreciation and impairment | ||
At 1 June | 0.6 | 0.8 |
Depreciation charge | 0.1 | 0.1 |
Exchange differences | (0.1) | (0.3) |
Transfers 3 | — | — |
At 31 May | 0.6 | 0.6 |
Net book value | ||
At 31 May | 10.0 | 6.6 |
Land and | Motor | Other | ||
buildings | vehicles | equipment | Total | |
£m | £m | £m | £m | |
Additions | 5.9 | — | 0.6 | 6.5 |
Depreciation charge in the year | (2.3) | (0.3) | (0.2) | (2.8) |
Net book value at 31 May 2025 | 12.6 | 0.1 | 0.9 | 13.6 |
PZ Wilmar Limited | |||
Long-term | Equity method | ||
loans | accounting | Total | |
£m | £m | £m | |
At 1 June 2023 | 40.3 | 11.7 | 52.0 |
Share of results of joint venture | — | 7.3 | 7.3 |
Loan repayments | (8.7) | — | (8.7) |
De-designation of permanent as equity loans | (30.6) | — | (30.6) |
Exchange differences | (1.0) | (19.0) | (20.0) |
At 31 May 2024 | — | — | — |
Share of results of joint venture | — | 5.6 | 5.6 |
Exchange differences | — | (1.0) | (1.0) |
Reclassification to assets held for sale | — | (4.6) | (4.6) |
At 31 May 2025 | — | — | — |
2025 | 2024 | |
£m | £m | |
Assets | ||
Non-current assets | 25.7 | 25.8 |
Current assets | ||
Cash and cash equivalents | 4.5 | 14.5 |
Other current assets | 51.2 | 35.7 |
55.7 | 50.2 | |
Total assets | 81.4 | 76.0 |
Liabilities | ||
Non-current liabilities | (47.7) | (54.1) |
Current liabilities | (24.4) | (22.9) |
Total liabilities | (72.1) | (77.0) |
Net assets/(liabilities) | 9.3 | (1.0) |
2025 | 2024 | |
£m | £m | |
Revenue | 189.6 | 202.6 |
Profit before taxation | 15.8 | 21.5 |
Profit after taxation | 11.1 | 14.6 |
Proportion of Group's ownership interest in the joint venture | 50% | 50% |
Share of results of joint venture | 5.6 | 7.3 |
2025 | 2024 | |
£m | £m | |
Raw materials and consumables | 11.9 | 11.5 |
Work in progress | 4.7 | 3.4 |
Finished goods and goods for resale | 53.4 | 53.6 |
70.0 | 68.5 |
2025 | 2024 | |
£m | £m | |
Trade receivables | 76.7 | 77.5 |
Less: loss allowance | (1.9) | (2.6) |
Net trade receivables | 74.8 | 74.9 |
Lease receivables | 1.2 | 1.3 |
Amounts owed by joint venture | 27.1 | 31.7 |
Other receivables | 12.6 | 14.9 |
Prepayments | 5.6 | 8.3 |
121.3 | 131.1 | |
Classified within: | ||
Current assets | 119.2 | 99.0 |
Non-current assets | 2.1 | 32.1 |
121.3 | 131.1 |
2025 | 2024 | |
£m | £m | |
At 1 June | (2.6) | (4.4) |
Increase in loss allowance | (0.8) | (1.9) |
Allowance used during the year | 0.1 | 0.6 |
Allowance released during the year | 1.4 | 2.0 |
Exchange differences | — | 1.1 |
At 31 May | (1.9) | (2.6) |
2025 | 2024 | |
£m | £m | |
Pound Sterling | 29.0 | 27.0 |
US Dollar | 11.7 | 11.6 |
Nigerian Naira | 3.5 | 4.7 |
Australian Dollar | 12.5 | 12.1 |
Indonesian Rupiah | 12.8 | 14.6 |
Other currencies | 5.3 | 4.9 |
74.8 | 74.9 |
Foreign | |||||
exchange | |||||
1 June 2024 | Net cash flow | movements | Other 1 | 31 May 2025 | |
£m | £m | £m | £m | £m | |
Cash at bank and in hand | 49.4 | (9.7) | (1.6) | — | 38.1 |
Short-term deposits | 1.9 | 5.2 | (0.1) | — | 7.0 |
Cash and cash equivalents 2 | 51.3 | (4.5) | (1.7) | — | 45.1 |
Current borrowings | (6.3) | 6.2 | 0.1 | (54.7) | (54.7) |
Non-current borrowings | (160.3) | 3.5 | — | 54.4 | (102.4) |
Net debt | (115.3) | 5.2 | (1.6) | (0.3) | (112.0) |
Lease liabilities | (12.1) | 3.3 | 0.2 | (6.3) | (14.9) |
Net debt including lease liabilities | (127.4) | 8.5 | (1.4) | (6.6) | (126.9) |
Foreign | |||||
exchange | |||||
1 June 2023 | Net cash flow | movements | Other 1 | 31 May 2024 | |
£m | £m | £m | £m | £m | |
Cash at bank and in hand | 127.4 | (22.7) | (55.3) | — | 49.4 |
Short-term deposits | 129.0 | (61.7) | (65.4) | — | 1.9 |
Cash and cash equivalents 2 | 256.4 | (84.4) | (120.7) | — | 51.3 |
Current asset investment | 0.5 | (0.5) | — | — | — |
Current borrowings | — | (6.4) | 0.1 | — | (6.3) |
Non-current borrowings | (251.2) | 91.0 | — | (0.1) | (160.3) |
Net cash/(debt) | 5.7 | (0.3) | (120.6) | (0.1) | (115.3) |
Lease liabilities | (13.0) | 2.9 | 0.2 | (2.2) | (12.1) |
Net debt including lease liabilities | (7.3) | 2.6 | (120.4) | (2.3) | (127.4) |
2025 | 2024 | |
£m | £m | |
Derivatives designated as hedging instruments | ||
Forward foreign exchange contracts | 0.3 | — |
Derivatives not designated as hedging instruments | ||
Forward foreign exchange contracts | 0.1 | — |
Financial assets at amortised cost | ||
Cash and cash equivalents | 45.1 | 51.3 |
Net trade and other receivables | 87.4 | 89.8 |
Lease receivables | 1.2 | 1.3 |
Trade receivables owed by joint venture | 0.7 | 1.1 |
Loan receivables owed by joint venture | 26.4 | 30.6 |
161.2 | 174.1 | |
Classified within: | ||
Current assets | 159.1 | 142.0 |
Non-current assets | 2.1 | 32.1 |
161.2 | 174.1 |
2025 | 2024 | |
£m | £m | |
Current interest-bearing borrowings at amortised cost | ||
Borrowings | 54.7 | 6.3 |
Non-current interest-bearing borrowings at amortised cost | ||
Borrowings | 102.4 | 160.3 |
Derivatives designated as hedging instruments | ||
Forward foreign exchange contracts | 0.2 | 0.3 |
Derivatives not designated as hedging instruments | ||
Forward foreign exchange contracts | 0.2 | 0.2 |
Other financial liabilities at fair value through profit or loss | ||
Other payables 1 | — | 4.5 |
Other financial liabilities at amortised cost | ||
Trade and other payables 2 | 149.3 | 151.9 |
Lease liabilities | 14.9 | 12.1 |
321.7 | 335.6 | |
Classified within: | ||
Current liabilities | 206.1 | 163.0 |
Non-current liabilities | 115.6 | 172.6 |
321.7 | 335.6 |
Foreign | |||||
exchange | |||||
1 June 2024 | Net cash flow | movements | Other | 31 May 2025 | |
£m | £m | £m | £m | £m | |
Non-current borrowings 1 | (160.3) | 3.5 | — | 54.4 | (102.4) |
Current borrowings 1 | (6.3) | 6.2 | 0.1 | (54.7) | (54.7) |
Lease liabilities | (12.1) | 3.3 | 0.2 | (6.3) | (14.9) |
Foreign | |||||
exchange | |||||
1 June 2023 | Net cash flow | movements | Other | 31 May 2024 | |
£m | £m | £m | £m | £m | |
Non-current borrowings 1 | (251.2) | 91.0 | — | (0.1) | (160.3) |
Current borrowings 2 | — | (6.4) | 0.1 | — | (6.3) |
Lease liabilities | (13.0) | 2.9 | 0.2 | (2.2) | (12.1) |
Notional | Fair value | ||||||
Weighted | |||||||
Local currency | average hedge | GBP equivalent | Average spot | Asset | Liability | ||
2025 | million | Currency pair | rate | £m | rate | £m | £m |
Sell USD | (13.8) | GBP:USD | 1.35 | 10.2 | 1.29 | — | — |
Buy EUR | 6.4 | GBP:EUR | 1.18 | (5.4) | 1.19 | 0.1 | (0.1) |
Sell AUD | (8.7) | GBP:AUD | 2.05 | 4.2 | 1.99 | 0.1 | — |
Buy USD | 24.1 | AUD:USD | 0.64 | (17.8) | 0.65 | 0.2 | (0.2) |
Buy IDR | 207,317.0 | GBP:IDR | 21,647 | (9.6) | 20,742 | — | (0.1) |
0.4 | (0.4) |
Notional | Fair value | ||||||
Weighted | |||||||
Currency | average hedge | GBP equivalent | Average spot | Asset | Liability | ||
2024 | million | Currency pair | rate | £m | rate | £m | £m |
Sell USD | (6.9) | GBP:USD | 1.27 | 5.4 | 1.27 | — | — |
Buy EUR | 7.7 | GBP:EUR | 1.16 | (6.6) | 1.16 | — | (0.1) |
Sell AUD | (4.2) | GBP:AUD | 1.92 | 2.2 | 1.92 | — | — |
Buy USD | 23.1 | AUD:USD | 0.66 | (18.3) | 0.66 | — | (0.2) |
Buy IDR | 134,365.4 | GBP:IDR | 20,103 | (6.7) | 19,550 | — | (0.2) |
— | (0.5) |
2025 | 2024 | |
£m | £m | |
At 1 June | (0.4) | 0.2 |
Fair value gains/(losses), net of taxation | 0.2 | (0.6) |
At 31 May | (0.2) | (0.4) |
2025 | 2024 | |||
Impact | Impact on | Impact on | Impact on | |
on profit | pre-tax | loss before | pre-tax | |
£m | before tax | equity | tax | equity |
US Dollar | (1.4) | 1.5 | 2.5 | 1.6 |
Nigerian Naira | 3.8 | — | 0.6 | — |
Chinese Renminbi | — | — | (0.2) | — |
2025 | 2024 | |||||
Impact on | Impact on | Impact on | Impact on | Impact on | Impact on | |
adjusted | operating | total | adjusted | operating | total | |
£m | operating profit | profit | equity | operating profit | loss | equity |
Nigerian Naira | (1.7) | (1.4) | (5.6) | (2.4) | 4.7 | (5.1) |
Indonesian Rupiah | (1.0) | (1.0) | (0.5) | (1.1) | (1.1) | (0.6) |
Australian Dollar | (1.3) | (1.2) | (0.8) | (1.2) | (1.2) | (2.7) |
Other | (0.6) | (0.6) | (2.2) | (0.6) | (0.3) | (2.3) |
Effect on profit/(loss) before tax | |||
Increase/decrease | 2025 | 2024 | |
in basis points | £m | £m | |
Nigerian Naira rates | +50 | 0.1 | 0.1 |
-50 | (0.1) | (0.1) |
Effect on profit/(loss) before tax | |||
Increase/decrease | 2025 | 2024 | |
in basis points | £m | £m | |
GBP rates | +50 | (0.8) | (0.8) |
-50 | 0.8 | 0.8 |
2025 | 2024 | |||
Cash and cash | Financial | Cash and cash | Financial | |
equivalents | derivatives | equivalents | derivatives | |
£m | £m | £m | £m | |
AA- | 4.1 | 0.2 | 6.8 | — |
A+ to A- | 19.6 | 0.2 | 20.8 | — |
BBB+ to BBB- | 0.4 | — | 0.9 | — |
BB+ to BB- | — | — | 2.6 | — |
B+ to B- | 20.8 | — | 20.2 | — |
not rated | 0.2 | — | — | — |
45.1 | 0.4 | 51.3 | — |
Expected credit | Gross trade | Lifetime expected | Net trade | |
loss rate | receivables | credit loss | receivables | |
At 31 May 2025 | % | £m | £m | £m |
Not past due | 0.0% | 65.2 | — | 65.2 |
Past due 0-30 days | 1.4% | 7.0 | (0.1) | 6.9 |
Past due 31-60 days | 12.5% | 0.8 | (0.1) | 0.7 |
Past due 61-90 days | 9.1% | 1.1 | (0.1) | 1.0 |
Past due 91-180 days | 11.1% | 0.9 | (0.1) | 0.8 |
Past due >180 days | 88.2% | 1.7 | (1.5) | 0.2 |
76.7 | (1.9) | 74.8 | ||
Specific provision | — | |||
Net trade receivables | 74.8 |
Expected credit | Gross trade | Lifetime expected | Net trade | |
loss rate | receivables | credit loss | receivables | |
At 31 May 2024 | % | £m | £m | £m |
Not past due | 0.1% | 67.4 | (0.1) | 67.3 |
Past due 0-30 days | 3.6% | 5.5 | (0.2) | 5.3 |
Past due 31-60 days | 9.1% | 1.1 | (0.1) | 1.0 |
Past due 61-90 days | 30.0% | 1.0 | (0.3) | 0.7 |
Past due 91-180 days | 33.3% | 0.9 | (0.3) | 0.6 |
Past due >180 days | 100.0% | 1.6 | (1.6) | — |
77.5 | (2.6) | 74.9 | ||
Specific provision | — | |||
Net trade receivables | 74.9 |
<3 months | 3-12 months | 1-2 years | 2-5 years | >5 years | Total | |
At 31 May 2025 | £m | £m | £m | £m | £m | £m |
Trade and other payables | (143.3) | (11.8) | (0.6) | — | — | (155.7) |
Forward foreign exchange contracts | (33.2) | (23.6) | — | — | — | (56.8) |
Borrowings | — | (54.7) | (69.9) | (32.5) | — | (157.1) |
Lease liabilities | (0.7) | (2.1) | (2.7) | (6.9) | (4.0) | (16.4) |
<3 months | 3-12 months | 1-2 years | 2-5 years | >5 years | Total | |
At 31 May 2024 | £m | £m | £m | £m | £m | £m |
Trade and other payables | (158.7) | — | (2.6) | — | — | (161.3) |
Forward foreign exchange contracts | (31.5) | (24.1) | — | — | — | (55.6) |
Borrowings | (8.7) | — | (125.0) | (36.0) | — | (169.7) |
Lease liabilities | (0.8) | (2.0) | (1.6) | (4.4) | (5.1) | (13.9) |
<3 months | 3-12 months | 1-2 years | 2-5 years | >5 years | Total | |
At 31 May 2025 | £m | £m | £m | £m | £m | £m |
Inflows | 33.4 | 23.4 | — | — | — | 56.8 |
Outflows | (33.2) | (23.6) | — | — | — | (56.8) |
Net | 0.2 | (0.2) | — | — | — | — |
Carrying amounts: | ||||||
Asset | 0.3 | 0.1 | — | — | — | 0.4 |
Liability | (0.1) | (0.3) | — | — | — | (0.4) |
0.2 | (0.2) | — | — | — | — |
<3 months | 3-12 months | 1-2 years | 2-5 years | >5 years | Total | |
At 31 May 2024 | £m | £m | £m | £m | £m | £m |
Inflows | 31.4 | 23.7 | — | — | — | 55.1 |
Outflows | (31.5) | (24.1) | — | — | — | (55.6) |
Net | (0.1) | (0.4) | — | — | — | (0.5) |
Carrying amounts: | ||||||
Asset | — | — | — | — | — | — |
Liability | (0.1) | (0.4) | — | — | — | (0.5) |
(0.1) | (0.4) | — | — | — | (0.5) |
Level 1 | Level 2 | Level 3 | Total | |
At 31 May 2025 | £m | £m | £m | £m |
Assets held at fair value | ||||
Derivative financial assets | — | 0.4 | — | 0.4 |
Liabilities held at fair value | ||||
Derivative financial liabilities | — | 0.4 | — | 0.4 |
Other payables | — | — | — | — |
Level 1 | Level 2 | Level 3 | Total | |
At 31 May 2024 | £m | £m | £m | £m |
Assets held at fair value | ||||
Derivative financial assets | — | — | — | — |
Liabilities held at fair value | ||||
Derivative financial liabilities | — | 0.5 | — | 0.5 |
Other payables | — | — | 4.5 | 4.5 |
2025 | 2024 | |
£m | £m | |
Current | ||
Trade payables | 72.5 | 66.8 |
Trade obligations with banks | — | 12.8 |
Other taxation and social security | 6.4 | 4.9 |
Other payables | 4.9 | 5.6 |
Accruals | 71.3 | 68.6 |
155.1 | 158.7 | |
Non-current | ||
Other payables | 0.6 | 2.6 |
0.6 | 2.6 |
Revaluation | |||||||||
Property, | Retirement | of property, | |||||||
plant and | benefit | plant and | Unremitted | Business | Accruals and | Other timing | |||
equipment | obligations | equipment | earnings | combinations | provisions | Tax losses | differences | Total | |
£m | £m | £m | £m | £m | £m | £m | £m | £m | |
At 1 June 2023 | (9.9) | (6.6) | (4.8) | (1.8) | (45.2) | 3.8 | 3.6 | (8.5) | (69.4) |
(Charge)/Credit to income | (2.0) | 0.2 | 4.8 | 1.8 | 6.1 | (1.0) | 29.5 | 4.2 | 43.6 |
statement | |||||||||
Credit/(Charge) to other comprehensive income | — | 1.7 | — | — | — | — | 13.6 | (0.5) | 14.8 |
Exchange differences | 4.7 | (0.4) | — | — | (0.1) | (1.3) | (9.9) | 0.4 | (6.6) |
At 31 May 2024 | (7.2) | (5.1) | — | — | (39.2) | 1.5 | 36.8 | (4.4) | (17.6) |
Credit/(charge) to income | 0.8 | — | — | — | (4.1) | (0.6) | (8.0) | 12.9 | 1.0 |
statement | |||||||||
Credit/(charge) to other comprehensive income | — | 1.2 | — | — | 0.9 | — | — | (1.6) | 0.5 |
Exchange differences | 0.1 | (0.1) | — | — | — | (0.2) | (2.0) | — | (2.2) |
At 31 May 2025 | (6.3) | (4.0) | — | — | (42.4) | 0.7 | 26.8 | 6.9 | (18.3) |
2025 | 2024 | |
£m | £m | |
Deferred tax assets | 15.8 | 22.2 |
Deferred tax liabilities | (34.1) | (39.8) |
(18.3) | (17.6) |
Warranty | |
provisions | |
£m | |
At 1 June 2023 | 0.4 |
Exchange differences | (0.2) |
At 31 May 2024 | 0.2 |
Additions | 0.1 |
At 31 May 2025 | 0.3 |
Risk | Description | Mitigation |
Investment risk | The present value of the defined benefit pension schemes’ | As part of the financing of the funded schemes, they invest in |
liabilities is calculated using a discount rate (investment return) | assets with higher return expectations than lower risk bonds | |
determined by direct reference to high-quality corporate bond | that are the best match for the schemes’ liabilities. To control | |
yields (for IAS 19 Employee Benefits purposes) and gilt yields (for | the resulting investment risk, the funded schemes invest in | |
statutory funding and long-term funding purposes). If the return | diversified portfolios of growth assets with the balances invested | |
on scheme assets is less than these discount rates, the funding | in liability-matching bond assets designed to control interest rate | |
position of the schemes will fall. | risk (see below). The split between growth assets and liability- | |
matching bond assets for each funded scheme is regularly | ||
monitored to ensure investment risk is not excessive given the | ||
statutory funding assumptions and the schemes’ long-term | ||
funding objectives. | ||
Interest risk | A decrease in the corporate bond yield and/or gilt yield will | The funded schemes make use of liability-driven investment |
increase the present value of the schemes’ liabilities under | techniques to protect them against the majority of the interest | |
the IAS 19 Employee Benefits and statutory/long-term | rate risk inherent in their liabilities. This is achieved by investing | |
funding bases respectively. | in gilts and investment grade corporate bonds such that changes | |
in the schemes’ liabilities due to falling gilt and/or corporate | ||
bond yields are offset by similar movements in the value of the | ||
schemes’ overall assets. | ||
Reflecting the funded schemes’ focus on controlling interest | ||
risk relative to their statutory and long-term funding bases, the | ||
schemes’ liability matching bond portfolios are predominantly | ||
invested in gilts, with the balance invested in investment grade | ||
corporate bonds to increase the expected return on the plans’ | ||
assets in a risk-controlled way. In doing so, the exposures to | ||
investment grade corporate bonds also help mitigate the | ||
interest rate risk inherent in the schemes’ IAS 19 Employee | ||
Benefits liabilities. | ||
Inflation risk | A decrease in the corporate bond yield and/or gilt yield will | The schemes’ liability-matching bond assets are also designed |
increase the present value of the schemes’ liabilities under | to hedge the majority of the inflation rate risk inherent in | |
the IAS 19 Employee Benefits and statutory/long-term funding | the schemes’ liabilities. This is achieved by investing in | |
bases respectively. | index-linked gilts. | |
Longevity risk | The value of the schemes’ liabilities is calculated by reference | To help control longevity, risk all the schemes are closed to future |
to the best estimate of the life expectancy of each scheme’s | benefit accrual. | |
participants. An increase in life expectancy of the schemes’ | ||
participants will increase the schemes’ liabilities. | The schemes consider additional approaches to mitigating | |
longevity risk, for example by buying annuities with an insurance | ||
company to cover the schemes’ liabilities. |
2025 | 2024 | |||||
Assets | Obligations | Total | Assets | Obligations | Total | |
£m | £m | £m | £m | £m | £m | |
Main plan | 135.4 | (120.2) | 15.2 | 150.9 | (130.3) | 20.6 |
Directors' plan | 27.4 | (15.2) | 12.2 | 29.0 | (17.5) | 11.5 |
Expatriate plan | 78.4 | (39.5) | 38.9 | 86.3 | (44.1) | 42.2 |
Unfunded plan | — | (2.8) | (2.8) | — | (3.2) | (3.2) |
241.2 | (177.7) | 63.5 | 266.2 | (195.1) | 71.1 | |
Restrictions due to asset ceiling | (38.9) | (42.2) | ||||
Net asset | 24.6 | 28.9 | ||||
Classified as/within: | ||||||
Retirement benefit surplus | 27.4 | 32.1 | ||||
Retirement benefit and other long-term employee obligations | (2.8) | (3.2) | ||||
24.6 | 28.9 |
2025 | 2024 | |
£m | £m | |
At 1 June | 266.2 | 272.4 |
Recognised in Consolidated Income Statement: | ||
– administrative expense | (1.0) | (1.3) |
– finance income | 11.3 | 11.8 |
Recognised in Consolidated Statement of Other Comprehensive Income: | ||
– return on plan assets (excluding finance income) | (18.4) | 0.2 |
Not recognised within comprehensive income due to asset ceiling: | ||
– finance income | 2.2 | 2.4 |
– return on plan assets (excluding finance income) | (5.6) | (4.7) |
Employer contributions to the Unfunded plan | 0.2 | 0.2 |
Benefits paid | (13.7) | (14.8) |
At 31 May | 241.2 | 266.2 |
2025 | 2024 | |
£m | £m | |
Equities | 2.5 | 3.1 |
Bonds | 226.2 | 247.6 |
Cash and cash equivalents | 12.5 | 15.5 |
241.2 | 266.2 |
2025 | 2024 | |
£m | £m | |
At 1 June | (195.1) | (192.5) |
Recognised in Consolidated Income Statement: | ||
– finance expense | (9.8) | (10.0) |
Recognised in Consolidated Statement of Other Comprehensive Income: | ||
– re-measurement gain due to changes in demographic assumptions | 3.3 | 1.1 |
– re-measurement gain/(loss) due to changes in financial assumptions | 18.6 | (8.4) |
– re-measurement loss due to experience adjustments | (8.4) | (0.1) |
Benefits paid | 13.7 | 14.8 |
At 31 May | (177.7) | (195.1) |
2025 | 2024 | |
£m | £m | |
Administrative expense | (1.0) | (1.3) |
Finance income | 1.5 | 1.8 |
0.5 | 0.5 |
2025 | 2024 | |
£m | £m | |
Relating to plan assets: | ||
– return on plan assets (excluding finance income) | (18.4) | 0.2 |
Relating to plan defined benefit obligations: | ||
– re-measurement gain due to changes in demographic assumptions | 3.3 | 1.1 |
– re-measurement gain/(loss) due to changes in financial assumptions | 18.6 | (8.4) |
– re-measurement loss due to experience adjustments | (8.4) | (0.1) |
(4.9) | (7.2) |
2025 | 2024 | |
Rate of increase in retirement benefits in payment | ||
– pensions in payment | 2.7% | 3.1% |
– deferred pensions | 2.4% | 2.7% |
Discount rate | 5.8% | 5.2% |
Inflation (RPI) | 2.9% | 3.3% |
2025 | 2024 | |
years | years | |
Weighted average life expectancy on post-retirement mortality table used to determine benefit obligations | ||
– Member age 65 (current life expectancy) | 21.9 | 22.5 |
– Member age 45 (life expectancy at age 65) | 23.0 | 23.9 |
Change in assumption | Change in obligation | |
Discount rate | Decrease of 0.25% | Increase of 2.6% |
Inflation (RPI) | Increase of 0.25% | Increase of 2.4% |
Mortality | Increase in life expectancy of 1 year | Increase of 3.2% |
2025 | 2024 | |
£m | £m | |
At 1 June | (9.0) | (9.3) |
Recognised in Consolidated Income Statement: | ||
– administrative expenses | (1.2) | (1.1) |
– finance expenses | (0.6) | (0.6) |
Recognised in consolidated other comprehensive income: | ||
– re-measurement gain | 0.3 | 0.4 |
Benefits paid | 0.9 | 0.6 |
Exchange differences | 0.7 | 1.0 |
At 31 May | (8.9) | (9.0) |
Change in assumption | Change in obligation | |
Discount rate | Decrease of 1.0% | Increase of 7.9% |
Salary rate | Increase of 1.0% | Increase of 7.6% |
2025 | 2024 | |||
Number | Number | |||
000 | £m | 000 | £m | |
Authorised, allotted, issued and fully paid: | ||||
Ordinary shares of 1p each | 428,725 | 4.3 | 428,725 | 4.3 |
Total called up share capital | 428,725 | 4.3 | 428,725 | 4.3 |
SIP trust | ||
ESOT number | number | |
At 1 June 2023 | 9,996,496 | 98,920 |
Issued to satisfy options | (659,230) | — |
Transfers | (103,523) | 103,523 |
At 31 May 2024 | 9,233,743 | 202,443 |
Issued to satisfy options | (688,843) | — |
Transfers | (173,509) | 173,509 |
At 31 May 2025 | 8,371,391 | 375,952 |
Performance | Restricted | Deferred | |||
shares | shares | bonus shares | SIP | Total | |
number | number | number | number | number | |
Options/awards outstanding as at 1 June 2023 | 3,619,963 | 1,587,947 | 205,952 | 96,460 | 5,510,322 |
Options/awards issued | 18,463 | 2,488,823 | 173,836 | 125,802 | 2,806,924 |
Options/awards exercised | (209,476) | (449,754) | — | (3,278) | (662,508) |
Options/awards lapsed/forefeited 1 | (1,061,785) | (402,045) | — | (19,819) | (1,483,649) |
Options/awards outstanding as at 31 May 2024 | 2,367,165 | 3,224,971 | 379,788 | 199,165 | 6,171,089 |
Options/awards issued | 5,985 | 4,033,454 | 441,587 | 198,097 | 4,679,123 |
Options/awards exercised | (91,733) | (466,782) | (129,173) | (519) | (688,207) |
Options/awards lapsed/forfeited | (1,056,785) | (887,873) | — | (25,313) | (1,969,971) |
Options/awards outstanding as at 31 May 2025 | 1,224,632 | 5,903,770 | 692,202 | 371,430 | 8,192,034 |
Performance | Restricted | Deferred | |||
shares | shares | bonus shares | SIP | Total | |
number | number | number | number | number | |
31 May 2025 | — | — | — | 23,193 | 23,193 |
31 May 2026 | 1,224,632 | 441,698 | 89,222 | 50,492 | 1,806,044 |
31 May 2027 | — | 1,919,624 | 602,980 | 106,343 | 2,628,947 |
31 May 2028 | — | 3,542,448 | — | 191,402 | 3,733,850 |
Total | 1,224,632 | 5,903,770 | 692,202 | 371,430 | 8,192,034 |
Note | 2025 | 2024 | |
£m | £m | ||
Profit/(loss) before taxation 1 | 6.5 | (95.9) | |
Net finance expense and net monetary loss arising from hyperinflationary economies | 14.1 | 12.2 | |
Operating profit/(loss) | 20.6 | (83.7) | |
Depreciation | 10, 11, 12 | 8.0 | 10.2 |
Amortisation | 10 | 4.1 | 7.1 |
Impairment of intangible assets | 10 | 35.3 | 24.4 |
Impairment reversal of intangible assets | 10 | (16.5) | — |
Impairment of current asset investment | — | 0.5 | |
Impairment reversal of current asset investment | (0.5) | — | |
Profit on sale of assets | 4 | (1.1) | (1.8) |
Difference between pension charge and cash contributions | 1.1 | 1.7 | |
Share-based payments | 2.6 | 1.9 | |
Rental income classified as investing cash flows | (1.1) | — | |
Share of results of joint venture | (5.6) | (7.3) | |
Operating cash flows before movements in working capital | 46.9 | (47.0) | |
Movements in working capital: | |||
Inventories | (5.6) | 2.3 | |
Trade and other receivables | 1.6 | 15.3 | |
Trade and other payables | 5.6 | 77.5 | |
Provisions | 0.7 | (0.4) | |
Cash generated from operations | 49.2 | 47.7 |
2025 | 2024 | |
£m | £m | |
Short-term employee benefits | 2.4 | 2.2 |
Post-employment benefits | 0.1 | 0.1 |
Share-based payments | 1.2 | 0.7 |
3.7 | 3.0 |
Parent | |||||||
Country of | company’s | Proportion of | |||||
Company | Operation | incorporation | interest | voting interest Registered office address | |||
PZ Cussons (Holdings) Pty Limited | Holding company Australia | 100% | 100% | Level 3, 510 | Church Street Cremorne Victoria 3121 | ||
PZ Cussons Australia Pty Limited | Manufacturing | Australia | 100% | 100% | Level 3, 510 | Church Street Cremorne Victoria 3121 | |
PZ Cussons Beauty Australia | Holding company Australia | 100% | 100% | Level 3, 510 | Church Street Cremorne Victoria 3121 | ||
(Holdings) Pty Limited | |||||||
Rafferty’s Garden Pty Limited | Dormant | Australia | 100% | 100% | Level 3, 510 | Church Street Cremorne Victoria 3121 | |
United Laboratories Limited | Dormant | Australia | 100% | 100% | Level 3, 510 | Church Street Cremorne Victoria 3121 | |
PZ Cussons (New Zealand) Pty Limited Distribution | Australia | 100% | 100% | Level 3, 510 | Church Street Cremorne Victoria 3121 | ||
Paterson Services (Shanghai) Limited | Active | China | 100% | 100% | Suite 635, 6th Floor, No.2000 Pudong Ave. China | ||
(Shanghai) Pilot Free Trade Zone | |||||||
Bronson Holdings Limited | Holding company England | 100% | 100% | Manchester Business Park, 3500 Aviator Way, | |||
Manchester, M22 5TG | |||||||
Milk Ventures (UK) Limited | Holding company | England | 100% | 100% | Manchester Business Park, 3500 Aviator Way, | ||
Manchester, M22 5TG | |||||||
PZ Cussons (Holdings) Limited | Holding company England | 100% | 100% | Manchester Business Park, 3500 Aviator Way, | |||
Manchester, M22 5TG | |||||||
PZ Cussons (International Finance) | Provision of | Manchester Business Park, 3500 Aviator Way, | |||||
Limited | services to Group | England | 100% | 100% | Manchester, M22 5TG | ||
companies | |||||||
Provision of | Manchester Business Park, 3500 Aviator Way, | ||||||
PZ Cussons (International) Limited | services to Group | England | 100% | 100% | Manchester, M22 5TG | ||
companies | |||||||
PZ Cussons (UK) Limited | Manufacturing | England | 100% | 100% | Manchester Business Park, 3500 Aviator Way, | ||
Manchester, M22 5TG | |||||||
Distribution | Manchester Business Park, 3500 Aviator Way, | ||||||
PZ Cussons Beauty LLP1 | & Holding | England | 100% | – | Manchester, M22 5TG | ||
partnership | |||||||
Seven Scent Limited | Manufacturing | England | 100% | 100% | Agecroft Commerce Park, Lamplight Way, Swinton, | ||
Manchester, M27 8UJ | |||||||
St. Tropez Acquisition Co. Limited | Holding company England | 100% | 100% | Manchester Business Park, 3500 Aviator Way, | |||
Manchester, M22 5TG | |||||||
St. Tropez Holdings Limited | Holding company | England | 100% | 100% | Manchester Business Park, 3500 Aviator Way, | ||
Manchester, M22 5TG | |||||||
St. Tropez Operations Limited | Dormant | England | 100% | 100% | Manchester Business Park, 3500 Aviator Way, | ||
Manchester, M22 5TG | |||||||
Thermocool Engineering | Dormant | England | 100% | 100% | Manchester Business Park, 3500 Aviator Way, | ||
Company Limited | Manchester, M22 5TG | ||||||
PZ Cussons Acquisition Co Limited 3 | Holding company England | 100% | 100% | Manchester Business Park, 3500 Aviator Way, | |||
Manchester, United Kingdom, M22 5TG | |||||||
Tadley Holdings Limited | Holding company England | 100% | 100% | Manchester Business Park, 3500 Aviator Way, | |||
Manchester, United Kingdom, M22 5TG | |||||||
Childs Farm Ltd | Distribution | England | 100% | 100% | Manchester Business Park, 3500 Aviator Way, | ||
Manchester, United Kingdom, M22 5TG | |||||||
PZ Cussons Ghana PLC 3 | Distribution | Ghana | 100% | 100% | Plot 27/3-27/7, Sanyo Road, Tema, P. O. Box 628 | ||
Community 1, Tema | |||||||
Provision of | 1/F., Hing Lung Comm. Bldg., 68-74 Bonham Strand, | ||||||
Parnon (Hong Kong) Limited | services to Group | Hong Kong | 100% | 100% | Sheung Wan | ||
companies | |||||||
PZ Cussons (Hong Kong) Limited | Dormant | Hong Kong | 100% | 100% | Level 54, Hopewell Centre, 183 Queen’s Road East | ||
Provision of | 604, 'C' Wing Raylon Arcade Ram Mandir Road – Kondvita | ||||||
PZ Cussons India PVT Limited | services to Group | India | 100% | 100% | Road, Bhim Nagar, Andheri East, Mumbai 400093 | ||
companies |
Parent | ||||||
Country of | Company’s | Proportion of | ||||
Company | Operation | incorporation | interest | voting interest Registered Office address | ||
PT PZ Cussons Indonesia | Manufacturing | Indonesia | 100% | 100% | Jalan Halim Perdana Kusuma No. 144, Kebon Besar, | |
Batuceper, Tangerang, Banten, Indonesia | ||||||
PZ Cussons (Europe) Limited | Dormant | Ireland | 100% | 100% | The Greenway Ardilaun Court, 112-114 St Stephen’s | |
Green, Dublin, DO2 TD28, Ireland | ||||||
Childs Farm Europe Ltd | Dormant | Ireland | 100.00% | 100.00% | 4th Floor, 103/104 O'Connell Street, Limerick V94 AT85, | |
Co. Limerick, Ireland | ||||||
PZ Cussons East Africa Limited | Manufacturing | Kenya | 99.99% | 99.99% | Baba Dogo Road, Ruaraka, Nairobi, Kenya | |
Food For Life International Limited | Dormant | Nigeria | 99.99% | 99.99% | 45/47 Town Planning Way, Ilupeju, Lagos | |
Harefield Industrial Nigeria Limited | Distribution | Nigeria | 99.99% | 99.99% | 45/47 Town Planning Way, Ilupeju, Lagos | |
HPZ Limited2 | Manufacturing | Nigeria | 74.99% | 74.99% | 45/47 Town Planning Way, Ilupeju, Lagos | |
Nutricima Limited | Dormant | Nigeria | 99.99% | 99.99% | 45/47 Town Planning Way, Ilupeju, Lagos | |
PZ Cussons Nigeria PLC | Manufacturing | Nigeria | 73.27% | 73.27% | 45/47 Town Planning Way, Ilupeju, Lagos | |
Roberts Pharmaceuticals Limited | Dormant | Nigeria | 100% | 100% | 45/47 Town Planning Way, Ilupeju, Lagos | |
PZ Cussons Polska S.A. | Distribution | Poland | 100% | 100% | Ul. Chocimska 17, 00-791 Warszawa | |
Provision of | ||||||
PZ Cussons Singapore Private Limited | services to Group | Singapore | 100% | 100% | 5 Shenton Way, UIC Building #10-01, Singapore 068808 | |
companies | ||||||
Provision of | 35 Moo 4, Tessamphan Road, Ban Chang Sub-District, | |||||
Guardian Holdings Company Limited | services to Group | Thailand | 49.00% | 49.00% | Mueang Pathum Thani District, Pathum Thani Province | |
companies | ||||||
PZ Cussons (Thailand) Limited | Manufacturing | Thailand | 99.99% | 99.99% | 35 Moo 4, Tessamphan Road, Ban Chang Sub-District, | |
Mueang Pathum Thani District, Pathum Thani Province | ||||||
PZ Cussons Middle East and South | Dormant | UAE | 100% | 100% | PO Box 17233, | Jebel Ali, Dubai |
Asia FZE | ||||||
St. Tropez Inc. | Distribution | USA | 100% | 100% | 101 | Greenwich St. Suite #11c New York, NY 10006 |
Childs Farm, Inc. | Distribution | USA | 100% | 100% | 101 | Greenwich St. Suite #11c New York, NY 10006 |
Country of | ||||
Joint venture company | Operation | incorporation | Parent company’s interest | Registered office address |
PZ Wilmar Limited | Manufacturing | Nigeria | 50% | 45/47 Town Planning Way, Ilupeju, Lagos |